AbbVie (ABBV) reported Q1 adjusted earnings Friday of $2.46 per diluted share, up from $2.31 a year earlier.

Analysts polled by FactSet expected $2.38.

Net revenue for the quarter ended March 31 was $13.34 billion, up from $12.31 billion a year earlier.

Analysts surveyed by FactSet expected $12.93 billion.

For full-year 2025, the company said it now expects adjusted diluted earnings of $12.09 to $12.29, compared with its previous guidance of $11.99 to $12.19.

Analysts surveyed by FactSet expect $12.16.

Shares of the company were up more than 2% in recent premarket activity.